Joy Ventures

Joy Ventures is a venture capital firm based in Herzliya Pituach, Israel, that invests in and builds companies focused on wellness, emotional wellbeing, and consumer products for well-being, often leveraging neuro research. The firm manages a $50 million fund, typically investing between $250,000 and $10,000,000, with a sweet spot around $2 million, across stages from Series A to Pre-IPO. Beyond traditional venture capital, Joy Ventures also incubates new ventures from academic research and entrepreneurs, providing hands-on support to develop solutions for anti-stress and mood enhancement. Led by CEO Miri Polachek, the firm targets startups, incubators, and academic research in neuro wellness, HealthTech, and consumer products, with an expanding focus on international investments and holistic joy. Joy Ventures was founded around 2017 by the Israeli-Japanese Corundum Open Innovation Fund.

Joy Ventures is a venture builder and investment firm founded in 2017 that focuses on developing and funding consumer products aimed at wellbeing, particularly at the intersection of technology, human-centered design, and science. The firm supports startups across various stages, providing not only capital but also deep domain expertise, mentorship, and access to a global network of industry and academic partners. Joy Ventures has a strong emphasis on neuroscience and mental health innovation, recently rebranding as Corundum Neuroscience to reflect this sharpened focus on life-changing neuroscience solutions that enhance emotional and cognitive wellbeing[1][2][3].

Founded in 2017, Joy Ventures was initially based in Maryland, United States, and later also associated with Herzliya, Israel. The firm was established by key partners passionate about combining technology and science to create impactful consumer health products. Over time, Joy Ventures evolved from a general wellbeing-focused investor to a specialized neuroscience venture builder and fund, supporting startups from ideation through market launch with a unique model that blends funding with hands-on venture creation and technology development[1][3].

Core Differentiators

• Unique Investment Model: Joy Ventures operates as both a venture builder and fund, engaging deeply with startups from ideation to market launch rather than just providing capital[1][3].
• Domain Expertise: The firm’s focus on neuroscience and wellbeing allows it to offer specialized guidance and access to a network of scientific and industry experts[3].
• Global Network: Joy Ventures leverages connections with academic institutions and industry leaders worldwide to support portfolio companies[1].
• Operating Support: Beyond funding, the firm provides mentorship, strategic guidance, and operational resources to accelerate startup growth[1][3].

Role in the Broader Tech Landscape

Joy Ventures rides the growing trend of integrating neuroscience, technology, and consumer health to address mental and emotional wellbeing—a sector gaining urgency due to rising awareness of mental health challenges globally. The timing is favorable as advances in AI, deep tech, and human-centered design converge to enable innovative products that can improve quality of life. By focusing on early-stage neuroscience ventures, Joy Ventures influences the ecosystem by nurturing startups that could redefine mental health care and consumer wellness products[3][1].

Quick Take & Future Outlook

Looking ahead, Joy Ventures (now Corundum Neuroscience) is positioned to deepen its leadership in neuroscience innovation, likely expanding its portfolio of startups developing breakthrough technologies for mental and emotional health. Trends such as AI-driven diagnostics, personalized mental health solutions, and digital therapeutics will shape its journey. The firm’s integrated venture-building approach and specialized focus suggest it will continue to be a key catalyst in transforming neuroscience research into impactful consumer products, reinforcing its influence in the wellbeing and healthtech sectors[3][1].